Through Navican, patients at Intermountain can get tested on an internally developed NGS platform that gauges a range of actionable genes implicated in cancer.
Researchers have developed a positional mapping approach to be used in conjunction with exome sequencing to limit the search for causative variants.
The first apps will be for individuals at low risk for inherited forms of cancer and heart disease, and will require a doctor's permission.
The researchers hope that unbiased sequencing will improve their ability to identify infections caused by knee and hip replacements.
The service provides broad access to information that may be critical for physicians in providing precision cancer treatments.
In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.
Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.
According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.
National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.